• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol & QC Guide

  2026-05-22

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) is designed for sensitive and specific detection of rabbit primary antibodies in ELISA, Western blot, and immunohistochemistry workflows. This reagent is not intended for diagnostic or clinical applications, and its use is limited to research settings requiring high specificity and signal amplification.

• YAP-TEAD Regulation of Super-Enhancers in Surface Ectoderm F

  2026-05-22

  Wang et al. (2026) present a mechanistic study uncovering how the YAP-TEAD transcriptional complex orchestrates super-enhancer networks to direct early surface ectoderm commitment from pluripotent stem cells. These findings clarify the epigenetic regulation of lineage specification and provide a foundation for regenerative strategies targeting epithelial tissues.

• M344: Histone Deacetylase Inhibitor for Cancer Research

  2026-05-21

  M344 is a potent, cell-permeable histone deacetylase inhibitor uniquely positioned for translational oncology and HIV-1 latency studies. Its robust activity profile, when paired with strategic workflow optimization, enables advanced control over cell differentiation, apoptosis, and chromatin modulation in challenging experimental settings.

• Rotavirus Suppresses Nrf2-Driven Antioxidant Defense via Pro

  2026-05-21

  This study reveals that progressive rotavirus infection leads to a pronounced downregulation of the redox-sensitive transcription factor Nrf2 and its target genes, independent of classical redox or Keap1/Cul3-mediated turnover. The findings highlight a proteasome-dependent mechanism and suggest new avenues for targeting host antioxidant pathways during viral infections.

• Dehydroabietic Acid in Precision Metabolic Research: Beyond

  2026-05-20

  Discover how Dehydroabietic acid, a dual PPAR-α/γ agonist, enables advanced metabolic disorder research through precise modulation of lipid metabolism and insulin sensitivity. This article uniquely explores the compound’s integration with next-generation gene editing insights and assay design.

• Bradykinin B2 Receptor-Mediated Inhibition of Ileal Peristal

  2026-05-20

  This study establishes that bradykinin, acting via B2 receptors, inhibits the peristaltic reflex in the guinea pig ileum by raising the pressure threshold required for peristalsis. These mechanistic findings provide a foundation for understanding gastrointestinal motility regulation and inform the use of ACE inhibitors in related research contexts.

• Dlin-MC3-DMA: Ionizable Cationic Liposome for Advanced RNA D

  2026-05-19

  Dlin-MC3-DMA's unique ionizable cationic liposome chemistry delivers exceptional potency and safety for mRNA and siRNA therapeutics. Discover real-world protocol enhancements, troubleshooting strategies, and machine learning-guided innovations for LNP design that enable precise gene modulation across hepatic, immunological, and neuroinflammatory contexts.

• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-05-19

  This study uncovers SEMA3E as a crucial regulator of beige adipocyte differentiation and thermogenesis in mice, acting through β-catenin signaling. The findings provide mechanistic insight into adipose tissue browning, with implications for metabolic disease research and experimental modeling of adipocyte biology.

• Ibrexafungerp and Caspofungin: Efficacy Against Resistant C.

  2026-05-18

  Wiederhold et al. demonstrated that ibrexafungerp, a novel triterpenoid, has significant in vitro and in vivo activity against fluconazole-resistant Candida auris, even when the initiation of therapy is delayed. The results benchmark ibrexafungerp against caspofungin, reinforcing β-(1,3)-D-glucan biosynthesis inhibition as a central antifungal strategy with translational potential for resistant Candida infections.

• Ceftazidime in Translational Research: Mechanisms and Strate

  2026-05-18

  This thought-leadership article unpacks the mechanistic and translational significance of Ceftazidime, a third-generation cephalosporin, within the escalating context of multidrug-resistant Gram-negative infections. Grounded in recent genomic surveillance—especially the transmission dynamics of carbapenem-resistant Enterobacter cloacae—this piece offers strategic, evidence-based guidance for translational researchers. Emphasizing robust experimental design, protocol optimization, and the critical role of β-lactamase resistance, it positions APExBIO's Ceftazidime as an essential tool for advanced infection modeling and research reproducibility. Bridging mechanistic insight and practical strategy, this article stands apart from standard product pages by synthesizing epidemiological, molecular, and workflow perspectives.

• Ciprofloxacin Potentiates Ferroptosis via Mitochondrial Zinc

  2026-05-17

  This study demonstrates that ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells by promoting mitochondrial Zn²⁺ accumulation through the STING1–CAV2 pathway. The findings illuminate a context-dependent, dual regulatory role of ciprofloxacin in cell death, with implications for targeted cancer therapy.

• M344: Epigenetic Precision for Neuroblastoma and Beyond

  2026-05-16

  Explore the advanced applications of M344, a potent histone deacetylase inhibitor, in neuroblastoma research and cancer epigenetics. This in-depth analysis reveals novel assay considerations and translational insights not covered elsewhere.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-15

  This study by Miao et al. reveals that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via separate molecular pathways. The findings provide insight into fungal mastitis pathogenesis and offer a foundation for developing targeted prevention and experimental approaches.

• SB 431542: Mechanistic Insight and Translational Impact in F

  2026-05-15

  This article offers translational researchers a rigorous synthesis of mechanistic, experimental, and strategic perspectives on the ALK5 inhibitor SB 431542. By unpacking its selectivity, downstream signaling effects, and recent evidence—including the reversal of Anp32e-driven fibrosis—this thought-leadership piece moves beyond standard product pages to connect TGF-β pathway inhibition with actionable protocol decisions and future clinical research opportunities.

• NU7441 (KU-57788): Precision DNA-PK Inhibition in Cancer Res

  2026-05-14

  NU7441 (KU-57788) enables highly selective, nanomolar DNA-PK inhibition for oncology and DNA repair research, maximizing sensitivity to DNA damage and dissecting cell cycle responses. This guide details practical protocols, troubleshooting strategies, and the latest insights from gastric cancer immune escape studies.

16199 records 1/1080 page Next 12345 下5页 Last page